BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29052158)

  • 1. Estimating Health State Utility Values for Comorbidities.
    Ara R; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):89-94. PubMed ID: 29052158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using health state utility values in models exploring the cost-effectiveness of health technologies.
    Ara R; Wailoo A
    Value Health; 2012; 15(6):971-4. PubMed ID: 22999149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Joint Health Condition Utility Values.
    Thompson AJ; Sutton M; Payne K
    Value Health; 2019 Apr; 22(4):482-490. PubMed ID: 30975400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Mapping to Estimate Health State Utility Values.
    Ara R; Rowen D; Mukuria C
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):57-66. PubMed ID: 29052160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
    Paisley S
    Pharmacoeconomics; 2016 Jun; 34(6):597-608. PubMed ID: 26861793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Populating an economic model with health state utility values: moving toward better practice.
    Ara R; Brazier JE
    Value Health; 2010 Aug; 13(5):509-18. PubMed ID: 20230546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Health State Utility Values in Decision Models.
    Ara R; Brazier J; Zouraq IA
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):77-88. PubMed ID: 29052163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating health state utility values for comorbid health conditions using SF-6D data.
    Ara R; Brazier J
    Value Health; 2011; 14(5):740-5. PubMed ID: 21839413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    Peasgood T; Brazier J
    Pharmacoeconomics; 2015 Nov; 33(11):1101-5. PubMed ID: 26133293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
    Hendrix N; Kim DD; Patel KS; Devine B
    Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring health state utility values of parents of children with a serious illness.
    Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
    Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.